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I. Abstract 
Background: Dopamine (DA) is a neurotransmitter involved in movement, reward learning 
and addiction. Fast-scan cyclic voltammetry (FSCV) has long been an indispensable tool 
for monitoring real-time DA signaling. Development of polyimide fused silica-encased 
FSCV microelectrodes have made the technique more suitable for chronic DA monitoring 
(months) in vivo.  
Methods: In this study, electrically stimulated DA signals were evoked weekly in an effort 
to characterize the recovery time and stability of DA signals recorded long-term with silica-
encased chronic DA microelectrodes. Additionally, electrical conditioning (etching), 
previously shown to improve microelectrode sensitivity in vitro, was performed to 
investigate the long-term impact on DA monitoring in vivo. Changes in sensitivity were 
assessed by kinetic analysis of recorded DA signals resulting in parameters describing DA 
release ([DA]p; the concentration of DA release per stimulus pulse) and uptake (Vmax; 
maximal rate of DA uptake). 
Results: Data from this study demonstrate that the peak amplitude of evoked DA signals 
(DAmax) significantly decreases after surgery, recovers in about 4.5 weeks, and then 
stabilizes and remains consistent long-term (> 6 weeks). The same trend holds for kinetic 
parameters describing DA release and uptake. Additional data also demonstrate that 
electrical conditioning increases the magnitude and quality of DA signals recorded long-
term in vivo.  
Conclusions: Once recovered, electrically evoked DA signals recorded at the silica-
encased chronic DA microelectrode, and resulting kinetic parameters describing DA 
release and uptake, are stable long-term (months) and can be enhanced with electrical 
conditioning. 
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II. Introduction 
 
A. Dopamine 
Dopamine (DA) is a neurotransmitter implicated in motor function (Delaville et al., 2015; 
Emborg et al., 1998; Freed and Yamamoto, 1985; Haber, 2014) and reward-motivated 
behaviors (Haber, 2014; Schultz, 1997, 2002, 2007; Yawata et al., 2012). DA activity is 
also implicated in learning and memory (Packard and Knowlton 2002; Puig et al., 2014; 
Yawata et al., 2012). DA is highly implicated in reward-dependent learning (Cox et al., 
2015; Schultz, 1997, 2002; Wise, 2006), and drugs of abuse have been shown to increase 
DA levels in the brain (Di Chiara and Imperato, 1988; Cheer et al., 2005, 2007; Covey et 
al., 2013; Daberkow et al., 2013). Dysfunction of the DA system, through depletion of DA 
neurons, underlies the symptoms of Parkinson’s disease (Albin et al., 1989; Benazzouz et 
al., 2014). Because DA is involved in these important brain functions and dysfunctions, 
long-term monitoring of DA activity in the brain is crucial to investigate and elucidate 
these processes further.  
 
B. Microdialysis 
Upon activation, DA is exocytotically expelled (dopamine release) into the synapse and 
then taken back up into dopamine neurons, and adjacent cells (dopamine uptake). 
Monitoring DA neurotransmission (release and uptake) in vivo is challenging. One method 
of DA detection is microdialysis and subsequent chemical detection using high 
performance liquid chromatography (HPLC) or gas chromatography mass spectrometry 
(GC-MS).  HPLC and GC-MS have a high degree of sensitivity and specificity of detected 
substances, making them widely used methods for neurotransmitter detection. However, 
use of microdialysis to obtain extracellular perfusate containing neurotransmitters has 
spatial and temporal limitations.  The microdialysis probe implanted in the brain is 
approximately 200 – 300 μm in diameter which can cause significant tissue damage to the 
areas of implantation (Nesbitt et al., 2013). In addition, DA activity related to behavior 
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happens on short time scales (milliseconds to seconds); therefore, capturing DA in the 
dialysate in relation to a behavioral event can be a challenge (Nesbitt et al., 2015; Zhang et 
al., 2012). To effectively investigate how DA neurotransmission is related to behavior, it 
is important to most accurately measure the exact time of DA release and uptake in relation 
to behavioral events in real-time.  
 
C. Fast-scan cyclic voltammetry 
DA is included in a class of neurotransmitters known as the catecholamines. 
Catecholamines contain a dihydroxyphenol group with an amine group. These functional 
groups play an important role in their detection through electrochemical methods, as 
catecholamines are easily oxidized to their quinone form (Tsunoda, 2006). Fast-scan cyclic 
voltammetry (FSCV) is an electrochemical method to detect electroactive chemicals such 
as DA (Ewing et al., 1983). It has become a vital technique in the field of DA research due 
to the small size of the FSCV sensor (resulting in very little tissue damage in the brain) and 
ability to monitor DA on a millisecond time scale (i.e., “real-time”). 
FSCV utilizes a micron-sized carbon fiber (sensor of the microelectrode) to monitor DA 
(Fig. 1A). The electrochemical measurements are made every 100 ms, affording the 
opportunity to monitor DA activity in real-time with sub-second temporal resolution at the 
carbon fiber microelectrode (CFM) (Wightman et al., 1988). During FSCV, detection of 
DA is done by applying an electrical potential through the CFM and quantification of DA 
is done through the measurement of current change at the CFM in response to the applied 
potential. The potential applied at the CFM is cycled between a low voltage (-0.4 V) to 
high voltage (+1.3 V) and back to low voltage (-0.4 V) in a triangular waveform. During 
DA monitoring, these scans are repeated every 100 ms to give a cycle rate of 10 Hz (normal 
cycling). If DA is present at the CFM, DA is oxidized during the anodic sweep of the 
electrical potential to form dopamine-o-quinone, which is then reduced back to DA in the 
cathodic sweep of the potential (Fig. 1A). DA is identified by the characteristic oxidation 
peak (approx. +0.7 V; green in Fig. 1B colorplot) and reduction peak (approx. -0.3 V, blue 
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in Fig. 2B colorplot). Graphing the measured oxidative and reductive current against 
voltage provides a visual depiction known as a cyclic voltammogram (CV; upper right of 
Fig. 2B) that is specific to DA. FSCV also allows the quantification of concentration in 
release events. The flow of electrons to and from DA as it is oxidized and reduced are 
measured as current at the CFM and are directly proportional to the number of DA 
molecules undergoing electrolysis. This current can subsequently be converted to DA 
concentration by comparison to measurements of known concentrations in vitro 
(Kristensen et al., 1986; Sinkala et al., 2012). Therefore, FSCV at the CFM allows for 
monitoring DA with high temporal resolution, as well as high chemical specificity.  
There are two main methods of fabricating DA microelectrodes for FSCV. While both 
types utilize a single strand of carbon fiber as their DA sensor, two different materials are 
used to house (encase) the carbon fiber sensor. More commonly, glass-housed electrodes 
have been used in FSCV. This glass-housed FSCV microelectrode has been used with 
success in vivo for detection of DA primarily in acute recordings (several hours). The 
microdrive apparatus used to permanently affix the glass electrodes is relatively large and 
is not conducive for long-term DA monitoring in freely moving behavioral experiments. 
In addition, glass housings cannot be utilized in humans; therefore, an alternative housing 
material has been employed. A new type of silica-encased electrode has been developed 
which more readily allows for chronic (weeks to months) implantation and recording of 
DA in vivo (Clark et al., 2010). This CFM is smaller than then typical glass-housed CFM 
and requires no microdrive apparatus for chronic implantation, making it physically easier 
to affix and successfully use in long-term behavioral experiments with freely moving 
animals. Importantly, a modified version of this relatively new silica-housed chronic 
electrode has been approved and is being further developed for the therapeutic use in 
humans with DA dysfunction, such as Parkinson’s disease (Kishida et al., 2011).  
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D. Kinetic Analysis 
Employing computer analysis and modeling based on Michaelis-Menten enzyme kinetics, 
parameters describing DA release and uptake can be determined from individual DA 
signals (Wu et al., 2001, 2002). The ability to determine these changes in DA 
neurotransmission can be beneficial in elucidating possible mechanisms related to behavior 
or in response to drugs (Covey et al., 2013; Daberkow et al., 2013). In the present study, 
they provide additional measures to quantify the stability of DA signals over time. Total 
evoked DA (DAmax) is a balance between DA release, and DA uptake by the dopamine 
transporter (DAT) (Wu et al., 2001). During the stimulation of DA neurons, the DA signal 
is a combination of both release and uptake. Upon extinction of stimulation, the signal is 
composed solely of DA uptake while the DAT clears DA from the synaptic cleft, returning 
extracellular DA to basal levels. Kinetic parameters defining changes in DA release and 
uptake determined from recorded DA signals can be useful in more specifically describing 
specific DA activity in the brain, as well as further describing changes in implanted 
microelectrodes used long-term in vivo.  
 
E. Electrical Conditioning  
Electrical conditioning (etching) creates a fresh surface on the carbon fiber of the DA 
microelectrodes by sloughing off the outer layer of the carbon fiber sensor (Keithley et. al., 
2011; Takmakov et al., 2010). Etching increases surface roughness of the carbon fiber, 
increasing the available surface area for electrons from the oxidation and reduction of DA 
to be detected. Etching is done by increasing the voltammetric scan frequency parameters 
from the normal 10 Hz cycle rate (DA monitoring)  to a 60 Hz cycle rate (Etching) for a 
period of time (e.g., 30 min). After etching, the cycle rate is returned to the original/normal 
10Hz cycle rate to allow the electrode to stabilize for 15 min prior to DA monitoring. With 
this procedure, there is no increase in current or voltage applied to the electrode, only an 
increase in the frequency that the potential sweeps from its low voltage (-0.4 V) to its high 
voltage (+1.3 V) and back (-0.4 V). This etching procedure only removes a minuscule 
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amount of the carbon from the surface of the microelectrode (Takmakov et al., 2010); 
therefore, the etching procedure should not cause any significant damage to brain tissue. 
Etching has been shown to increase electrode sensitivity to DA in vitro (Takmakov et al., 
2010). Etching has only been used sparingly in vivo, prior to implantation surgery in acute 
experiments with glass-housed DA microelectrodes (Keithley et al., 2011; Sombers et al., 
2009), as well as in one published experiment with silica-housed DA microelectrodes 
(Oleson et al., 2014). However, in these experiments, etching was only utilized prior to DA 
electrode implantation surgery, and therefore, results relating to any increase in DA 
sensitivity in vivo were not reported. The effects of etching surgically implanted DA 
microelectrodes after recovery from implantation surgery, as well as the effect of 
successive (weekly) etching events in vivo, has not been previously described.  
 
III. Methods 
 
A. Animals 
Male, Sprague Dawley rats (250g-300g) were housed individually in a temperature-
controlled room, under a natural light/dark cycle (light cycle regulated by sunrise and 
sunset through windows in the animal housing area) and allowed access to food and water 
ad libitum. All animal care and experimental procedures conformed to the National 
Institute of Health Guide for the Care and Use of Laboratory Animals and were approved 
by the Institutional Animal Use and Care Committee at Eastern Washington University. 
 
B. Microelectrode placement and in vivo monitoring 
Rats (n=13) were implanted with stimulating, reference and chronic silica-encased DA 
microelectrodes. Implantation surgeries followed procedures similar to what is described 
in Daberkow et al. (2013) with the modification of utilizing silica-encased chronic 
electrodes (Clark et al., 2010) instead of a glass-housed acute electrode. Maximal DA 
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release and kinetic parameters describing DA release and uptake were tracked weekly 
over 12 weeks following implantation surgery, these measures were then compared to 
determine and quantify changes in the DA signals recorded long-term with the chronic 
DA FSCV microelectrode. 
On the day of surgery, rats were first deeply anesthetized. Initially anesthesia was induced 
with 4% isoflurane in 100% oxygen while the animal was housed in a sealed plexiglass 
box. After being rendered unconscious, rats were transferred to a stereotaxic frame 
(Stoelting Co.Wood Dale, IL, USA). A warm (37°C) heating pad was placed under the rat, 
and a nose cone was used to administer anesthesia throughout the electrode implantation 
surgery. During surgery, 1.9%-2.1% isoflurane in 100% oxygen was delivered through the 
nose cone. Percentage of isoflurane vaporized was monitored and maintained with a 
precision nebulizer. The appropriate depth of anesthesia was established through 
monitoring respiration rate and the absence of responses to a firm paw pinch. Depth of 
anesthesia was carefully assessed throughout the DA recording sessions. 
 
Once rats were immobilized in the stereotaxic frame. Skin and fascia were cleared, and 
small holes drilled in the skull for placement of electrodes. Stereotaxic coordinates were 
obtained from the atlas of Paxinos and Watson (1986). Using stereotaxic micromanipulator 
arms, a DA recording electrode was positioned in the dorsal striatum (+1.0 AP, +2.0 ML, 
-5.8 DV), a brain region highly innervated with DA neurons and strongly implicated in 
learning (Salamone and Correa, 2012). Then, a chlorinated silver wire (Ag/AgCl) reference 
electrode was lowered into the contralateral cortex just below the dura. Finally, a twisted 
bipolar stimulating electrode (Plastics One, Roanoke, VA) with ~1-mm tip separation was 
incrementally lowered and positioned just above the medial forebrain bundle (-4.6 AP, 
+1.4 ML, -7.5 DV). Constant current, biphasic stimulus pulses (60 Hz, 60 pulses, 300 µA; 
Oleson et al., 2013) were applied (NL 800, Neurolog, Medical Systems, Great Neck, NY), 
and the stimulating electrode was incrementally lowered until a robust DA signal was 
evoked. Once DA signals were monitored, a small (6mm x 4mm) headstage (Datamate 
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M80, Harwin, Salem, NH) was connected to the electrodes and affixed to the rat’s skull 
with dental cement. The headstage allowed for simple reconnection to recording equipment 
during subsequent DA monitoring sessions. Once the dental cement dried (25-30 min), the 
rat was removed from the stereotaxic frame and allowed to regain consciousness under 
delivery of 100% oxygen. 
One week after implantation surgery, electrode recovery testing began. Chronic DA 
microelectrodes require a period of recovery time before clear DA signals can be detected 
(Clark et al., 2010; Personal discussion at the Society for Neuroscience annual meeting 
2013 and 2014). Once a week, after surgery, rats were reconnected to recording equipment 
with a simple headstage clip (Datamate M80-667, Harwin, Salem, NH). Small stimulations 
(60 Hz, 24 pulses, 125 µA; Daberkow et al., 2013) were applied in attempt to evoke 
identifiable DA signals (NL 800, Neurolog, Medical Systems, Great Neck, NY). This 
procedure was repeated weekly until such DA signals were detected. Once clearly 
identifiable DA signals were observed, indicating recovery from surgery, rats began 
anesthetized stimulations for larger electrically-evoked DA signals conducive to kinetic 
analysis. For DA recording during these larger stimulations, rats were deeply anesthetized 
as described above, and reconnected to recording equipment with the headstage clip. 
Constant current, biphasic stimulus pulses (60 Hz, 60 pulses, 300 µA; Oleson et al., 2013) 
were applied, and DA signals were monitored. After three electrically-evoked DA signals 
were recorded, rats were disconnected from recording equipment, given pure oxygen, then 
returned to their home cage and allowed to regain consciousness.  
 
C. Kinetic Analysis 
DA signals were analyzed using a kinetic model describing evoked DA levels as a 
balance between DA uptake and release mechanisms (Wu et al., 2001) using the equation 
d[DA]/dt = [DA]p * f - Vmax/(Km/[DA] + 1). Based on curve fitting of DA signals to this 
equation utilizing computer modeling software, parameters describing exocytotic DA 
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release ([DA]p; DA release per stimulus pulse) and DA uptake (Vmax; maximal velocity of 
DA uptake) were determined (Wu et al., 2001, 2002). 
 
D. Electrical Conditioning  
Once electrodes were surgically implanted and clear DA signals re-appeared after 
recovery from surgery, electrical conditioning (etching) treatments began. A series of 
three electrically evoked DA signals were recorded prior to etching as described above 
(pre-etch signals). Etching was then done for a period of 30 min at an increased 
frequency of 60 Hz voltammetric cycling rate (Takmakov et al., 2010). The cycling rate 
was then returned to the normal 10 Hz cycle rate for a period of 15 min after etching to 
allow the electrode to stabilize. A series of three electrically evoked DA signals were 
recorded after etching (post-etch signals). Rats were then disconnected from recording 
equipment and returned to their home cage to regain consciousness. Peak height of DA 
signals ([DA]max) and cyclic voltammograms, from pre-etch and post-etch were compared 
to determine the impact of etching on microelectrode sensitivity and ability to accurately 
detect DA (Fig. 11-14). 
 
E. Statistical analysis 
Changes in [DA]max, [DA]p, and Vmax were statistically analyzed with  a one-way ANOVA, 
using  weeks post-surgery as the independent variable, followed by sequential Tukey’s 
post-hoc tests. Etching data was also analyzed with a one-way ANOVA, using weekly 
etching treatment event as the independent variable. Cyclic voltammogram (CV) data were 
analyzed using a Spearman’s rank correlation test followed by a Williams’s test to 
determine significance of the fit of the data compared to the standard CV. All statistical 
analyses were performed utilizing R 3.2.0 software program for windows (The R 
Foundation for Statistical Computing). Significance level was set at p<0.05.  
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IV. Results  
The range of electrode recovery time was 3 to 7 weeks (Fig. 2, n=13). The average recovery 
time was 4.5 weeks post-surgery with a median of 4 weeks (Fig. 3).  
 
Once recovered from surgery, electrically evoked DA stimulation was preformed to 
characterize the changes in recovered DA signals. Initially, there was a significant 
reduction in the total evoked DA from the day of implantation surgery to subsequent 
recovered DA signals (Fig. 5, [DA]max, p=0.024). However, once DA signals recovered 
there were no significant differences in total evoked DA values between weekly recorded 
DA signals  (Fig. 6, [DA]max, p=0.482).  
 
A similar trend was found for kinetic parameters describing DA release ([DA]p). There was 
a significant  decrease between the DA release at the time of surgery compared to values 
from signals recorded in subsequent weeks following post-surgery signal recovery (Fig. 7, 
[DA]p, p<0.001). However, there were no differences found in DA release parameters 
following recovery out to twelve weeks post-surgery (Fig. 8, [DA]p, p=0.173).  
 
The kinetic parameters describing uptake similarly showed a significant decrease between 
the recovered DA uptake values when compared to the uptake values recorded at the time 
of surgery (Fig. 9, Vmax, p<0.001). Importantly, DA uptake values remained stable after 
signal recovery with no significant changes over subsequent weeks (Fig. 10, Vmax, 
p=0.115).  
 
Total evoked DA currents were also recorded and analyzed prior to, and after, etching. The 
mean DA current prior to etching was  11.37 nA (± 1.34 nA, standard error), and the mean 
DA current after etching was  17.08 nA (± 2.20nA, standard error), demonstrating a 
significant increase in DA current after etching for 30 minutes at 60 Hz (Fig. 13, p=0.0321). 
Figure 12 shows the percent increase in DA current by etch number through six etching 
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treatments. The range of DA current percent change was -20.21% to +176.79%. The mean 
percentage increase averaged across all six etchings was 52.23% (± 9.40%, standard error). 
These data demonstrate a significant increase from pre-etch signals to post-etch signals 
(Fig. 13, p=0.0321). When the number of etching events was added as an independent 
variable in statistical analysis, there was no significant difference between the etchings 
(Fig. 12, p=0.529).  
 
While most animals had an increase in DA current after etching, there were two animals 
that displayed a decrease in DA current after etching treatment. However, even though the 
DA current was reduced in these animals, the cyclic voltammograms were “cleaner”. A 
cleaner voltammogram is defined as a voltammogram shape that is more similar to a 
standard DA voltammogram obtained during flow cell injection of a known concentration 
of DA (1 µM; Kristensen et. al., 1986, Sinkala et. al., 2012). A series of DA signals of 
various sizes (nA) were obtained during implantation surgery. A surgery DA signal of 
similar size (nA) as the pre-etch and post-etch DA signals was defined as the standard 
voltammogram. This standard signal was plotted together with the pre-etched and post-
etched voltammograms (Fig. 14). To determine if there was a significant improvement in 
the voltammogram after etching, the pre-etched and post-etched voltammograms were 
compared to the standard voltammogram using a Spearman rank correlation test to obtain 
the correlation value. The correlation parameter for the pre-etch voltammogram compared 
to the standard was 0.66, and the post-etch voltammogram compared to standard 
correlation parameter was 0.74. A Williams’s test was then used to determine that these 
correlation values were significantly different from each other (p<0.001). This analysis 
verified that the post-etch voltammogram was more similar to a standard voltammogram 
than the pre-etched. 
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V. Discussion 
The aim of the present study was three fold. The first objective was to determine the amount 
of time required for viable DA signals to return after implantation of the chronic DA 
microelectrode. The results of this study demonstrate that electrically evoked DA signals 
require approximately 4.5 weeks to recover after implantation surgery (Fig. 2-3).  
 
Secondly, this study aimed to determine if recovered DA signals, as well as kinetic 
parameters describing DA release ([DA]p) and uptake (Vmax), remain stable long-term.   
The results demonstrate that there is an initial reduction in total evoked DA ([DA]max), 
[DA]p, and Vmax until DA signal recovery (Fig. 5, 7, 9). However, once DA signals recover 
from implantation surgery, these values remain consistent long-term (Fig. 6, 8, 10). These 
data suggest that once recovered, the DA signals recorded at the chronic DA 
microelectrode remain stable long-term.  
 
While these data suggest long-term stability of the CFM, the data do not explain the 
significant reduction in total evoked DA, as well as the decrease in the kinetic parameters 
describing DA release and uptake after implantation surgery.  A possible explanation for 
these effects is the likely disturbance of tissue surrounding implanted electrodes during and 
after placement. It has been shown previously that similar electrodes implanted in the brain 
can lead to encapsulation of the electrodes by microglial cells and astrocytes (Duff and 
O’Neill 1994; Markwardt et al., 2013; Seymore and Kipke 2007; Kozai et al., 2012). 
However, it has also been previously demonstrated that small probes such as the CFM do 
not cause significant levels of encapsulation by microglia and astrocytes around the carbon 
fiber sensor (Seymore and Kipke 2007; Clarke et al., 2010). Therefore, it is more likely 
that encapsulation is occurring around either the reference electrode and/or surrounding the 
stimulating electrode as these electrodes are significantly larger in size. In either case, 
encapsulation could likely explain the reduction of signals recorded during surgery until 
electrode signal recovery. Encapsulation of the stimulating electrode could create 
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additional cell layers which the electrical stimulating current would have to travel through 
prior to reaching the medial forebrain bundle (Kozai et al., 2012). This could induce a 
reduction in realized current at the medial forebrain bundle, and thus cause a reduction in 
the magnitude of stimulation resulting in an overall smaller evoked DA release event. 
Encapsulation of the reference electrode, causing an additional cell layer, could reduce the 
effective applied waveform current which could potentially reduce the ability to oxidize 
and reduce the DA surrounding the CFM. Further research is needed to determine the 
precise location(s) and extent of encapsulation(s) after chronic implantation of all 
electrodes. Additionally, it would be useful to investigate potential procedures to minimize 
electrode encapsulation (Azemi et. al., 2008, 2011). 
 
The first two aims of this study support the continued use and further development of the 
CFM for use in long-term studies. While there are still some unanswered questions 
regarding the mechanisms causing reduction in post-implantation signals, the fact that the 
DA signals recover and remain stable for several weeks demonstrates that these chronic 
DA microsensors are beneficial for long-term in vivo studies where use of glass electrodes 
would be more difficult or prohibited (i.e., in humans; Kishida 2011). 
 
Finally, the third objective of this study was to investigate the effect of electrical 
conditioning (etching) in vivo after electrode implantation. The results suggest that 
electrical etching provides a significant increase in the DA current measured at the CFM 
(Fig. 13). While most animals had an increase in DA current after etching, there were two 
animals that displayed a decrease in DA current after etching treatment. Analysis of 
voltammograms verified that the post-etch voltammogram is more similar to a standard 
voltammogram than the pre-etched. These data validate that electrical conditioning 
significantly improves the DA signature signal (cyclic voltammogram, CV) measured with 
the chronic DA microelectrode long-term (Fig. 14). A cleaner cyclic voltammogram allows 
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for greater microelectrode reliability and certainty that the current detected at the CFM is 
DA.  
 
It is important to note that there is a limit to the amount of etching that can be done on an 
electrode. In 2010, Takmakov et al. showed that carbon fiber in an electrode will 
completely disappear after etching for a period of 30 hrs. In addition, the data from the 
present study suggest a trend in which the first, and last two etchings displayed the greatest 
increase in DA current, while etchings 3 and 4 remain below the average percent increase 
(Fig. 12). It may be beneficial to limit the etching in an experiment to the initial recording 
sessions in order to preserve the amount of carbon fiber available.  
 
Overall, this study demonstrates the viability of the CFM for use in long-term in vivo 
studies. In addition, these results support the use of successive etchings in vivo as a 
treatment to increase the magnitude and quality of long-term recorded DA signals in 
experiments utilizing FSCV. 
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Fig. 1. Fast Scan Cyclic Voltammetry (FSCV) at the carbon fiber microelectrode. A, 
Diagrammatic carbon fiber microelectrode sensor (radius = 7 μm) shown in dark blue 
encased in silica tubing (light blue). Oxidation of dopamine to dopamine-o-quinone and 
reduction of dopamine-o-quinone to dopamine. B, Upper right, dopamine cyclic 
voltammogram showing dopamine oxidation (positive peak) and reduction (negative peak) 
identifying measured current as dopamine. Lower figure, FSCV color plot with dopamine 
oxidation (green) and reduction (blue) showing peak voltages of for dopamine oxidation 
(+0.7 V) and dopamine reduction (-0.3 V).   
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Fig. 2. Histogram of electrode recovery times. The range of recovery times was 3 to 7 
weeks for the electrode signal to recover.  
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Fig. 3. Box plot of electrode recovery times. The gray box represents 50 percent of the 
data, whiskers include the inter-quartile range representing 75 percent of the data, and the 
bold solid line is the median. The mean microelectrode recovery time was 4.538 weeks 
after implantation surgery. Symbols represent outlier (°) and mean (Δ). 
 
 
 
 
 
21 
 
 
 
Fig. 4. Representative electrically evoked dopamine signals. A, Evoked dopamine signal 
recorded during implantation surgery. Upper right, dopamine voltammogram showing 
dopamine oxidation (positive peak) and reduction (negative peak) identifying measured 
current as dopamine. Middle, dopamine current plotted against time showing total evoked 
dopamine signal. Lower figure, FSCV color plot with dopamine oxidation (green) and 
reduction (blue) showing peak voltages for dopamine oxidation (+0.7 V) and dopamine 
reduction (-0.3 V). B, Evoked dopamine signal recorded 5 weeks after surgery. Upper right, 
dopamine voltammogram showing dopamine oxidation (positive peak) and reduction 
(negative peak) identifying measured current as dopamine. Middle, dopamine current 
plotted against time showing total evoked dopamine signal. Lower figure, FSCV color plot 
with dopamine oxidation (green) and reduction (blue) showing peak voltages for dopamine 
oxidation (+0.7 V) and dopamine reduction (-0.3 V).  
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Fig. 5. Box plot showing total evoked dopamine from implantation to 12 weeks after 
surgery. There was a significant reduction in total evoked dopamine from implantation 
surgery values to the recovered signal values, while weeks 3 to 12 had no significant 
differences. Symbols represent mean (Δ). * p < 0.05, significantly different than weeks 3 
through 12 determined by one-way ANOVA and Tukey’s post hoc analysis (n=7). 
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Fig. 6. Box plot of total evoked dopamine after electrode recovery, 3 to 12 weeks after 
surgery. Symbols represent mean (Δ). Once recovered, total evoked dopamine remained 
stable with no significant differences (one-way ANOVA, p=0.482). 
24 
 
 
Fig. 7. Box plot of dopamine release from implantation to 12 weeks after surgery. 
Dopamine release ([DA]p) has a significant reduction from implantation surgery values to 
the recovered signal values, while weeks 3 to 12 had no significant differences. Symbols 
mean (Δ). * p < 0.01, significantly different than week 3 through 12 determined by one-
way ANOVA and Tukey’s post hoc analysis (n=7). 
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Fig. 8. Box plot of dopamine release ([DA]p) after electrode recovery to 12 weeks after 
surgery. Symbols represent mean (Δ). [DA]p remains stable after electrode recovery with 
no significant differences between weeks (one-way ANOVA, p=0.173). 
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Fig. 9. Box plot of dopamine uptake from implantation to 12 weeks after surgery. There 
was a significant reduction in dopamine uptake (Vmax) from implantation surgery values to 
the recovered signal values, while weeks 3 to 12 had no significant differences. Symbols 
represent outlier (°) and mean (Δ). * p < 0.01, significantly different than week 3 through 
12 determined by one-way ANOVA and Tukey’s post hoc analysis (n=7). 
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Fig. 10. Box plot of dopamine uptake (Vmax) after electrode recovery to 12 weeks after 
surgery. Symbols represent outlier (°) and mean (Δ). Vmax remains stable after electrode 
recovery with no significant differences between weeks (one-way ANOVA, p=0.115). 
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Fig. 11. Representative electrically evoked dopamine signals before and after electrical 
conditioning (etching). A, Evoked dopamine signal recorded prior to etching. Upper right, 
dopamine voltammogram showing dopamine oxidation (positive peak) and reduction 
(negative peak) identifying measured current as dopamine. Middle, dopamine current 
plotted against time showing total evoked dopamine signal. Lower figure, FSCV color plot 
with dopamine oxidation (green) and reduction (blue) showing peak voltages for dopamine 
oxidation (+0.7 V) and dopamine reduction (-0.3 V). B, Evoked dopamine signal recorded 
after etching at 60 Hz for 30 min. Upper right, dopamine voltammogram showing 
dopamine oxidation (positive peak) and reduction (negative peak) identifying measured 
current as dopamine. Middle, dopamine current plotted against time showing total evoked 
dopamine signal. Lower figure, FSCV color plot with dopamine oxidation (green) and 
reduction (blue) showing peak voltages for dopamine oxidation (+0.7 V) and dopamine 
reduction (-0.3 V).  
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Fig. 12. Box plot showing the percent change in dopamine current after electrical 
conditioning (etching) for 30 min at 60 Hz. Percent dopamine increased an average of 
52.23% over 6 etching treatments. The percent change in dopamine current had a range 
from -20.21% to +176.79%. Symbols represent outlier (°) and mean (Δ). 
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Fig. 13. Box plot showing evoked dopamine current (nA) prior to electrical conditioning 
(etching) compared to that after etching for 30 min at 60 Hz. Electrically evoked dopamine 
current increased significantly after electrical conditioning. Symbols represent outlier (°) 
and mean (Δ). * p < 0.05, significantly different than post-etch determined by one-way 
ANOVA (n=6). 
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Fig. 14. Dopamine is identified by the characteristic oxidation peak (approx. +0.7 V) and 
reduction peak (approx. -0.3 V). Graphing the measured oxidative and reductive current 
against voltage provides a visual depiction, known as a cyclic voltammogram (CV), 
specific to dopamine. Pre-etch and post-etch dopamine CVs were compared to a standard 
dopamine CV. The post-etch dopamine CV was more similar to a standard dopamine CV 
verified through a Spearman’s rank correlation test with subsequent Williams’s test 
(p<0.0001). 
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